This forum post is hidden because you have chosen to ignore mbillingsley. Show Details
This forum post is hidden because you have submitted an abuse report against it. Show Details
BMJ news reports that the guidance is supported by " the BMA, the Academy of Medical Royal Colleges, and the royal colleges of GPs, physicians, and psychiatrists. The Department of Health for England, the NHS Confederation, and the governments of Scotland and Wales also back the guide, which is aimed at achieving better cooperation with the industry for the benefit of patients at a time of budgetary constraint."
Accoding to a letter/Rapid reponse in the BMJ - "it takes some sleuthing to discover that the guideline is written bt a multinational stakeholder group, seemingly coordinated by the Association of the British Pharmaceutical Industry (ABPI). Neither the group's membership or funding is declared in the guidance or the ABPI website. So much for transparency."
It has surprised some people that major medical organisations have backed this report, without enquring into the authors links to industry or the evidence used in the report to back up claims.
There are concerns about doctors' collaboration with the drug industry - are there conflict of interest if a drug company pays for a dinner or accomodation etc. Does this collaboration impact on clinical decisions made?